Session V: Oral Presentations
AGENDA
LECTURES
Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
C. Oreja-Guevara
COVID-19 in Multiple Sclerosis Patients in Dubai: Observational Study
M. Thakre
Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients
A. Dahshan
Radiologically Isolated Syndrome Conversion to Multiple Sclerosis
F. Sabeti
Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
H. K. Hassoun
Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study
B. Yamout
VIDEO